Skip to main content

Table 1 Death rates and cumulative incidence functions stratified by treatment groupa

From: Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments

 

Control

(n = 144,816)

EBRT

(n = 44,318)

BT

(n = 14,259)

BT + EBRT

(n = 11,835)

RP

(n = 26,790)

RP + EBRT

(n = 1557)

Cryotherapy

(n = 2115)

Number of deaths (%)

44,955 (31.0)

10, 522 (23.7)

1830 (12.8)

1658 (14.0)

3365 (12.6)

162 (10.4)

192 (9.1)

KM 10-yr. CIF(%)

50.5

44.0

30.1

30.5

19.3

23.8

32.1

95% Confidence Interval for KM 10-yr. CIF

50.1, 50.9

43.1, 44.8

28.4, 31.8

28.8, 32.2

18.6, 20.1

19.8, 28.0

25.4, 39.0

  1. Abbreviations: KM Kaplan-Meier, CR competing risks, HR hazard ratio, CI confidence interval
  2. a EBRT external beam radiotherapy, BT brachytherapy, RP radical prostatectomy